Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locallyadvanced carcinoma of the breast. - de Matteis,A.; Nuzzo,F.; D'Aiuto,G.; Labonia,V.; Landi,G.; Rossi,E.; Mastro,A.A.; Botti,G.; De Maio,E.; Perrone,F. (Cancer, 2002)